Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

PURE Sturdy: New insights into anthropometrics and cardiovascular outcomes in 142,000 adults from 21 countries followed for 9 years

Presentation ESC 2019

PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years

Presenter: Darryl P. Leong

September 02, 2019

Presentation ESC 2019

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Presenter: Johannes Neumann

September 01, 2019

Presentation ESC 2019

One-year Outcomes After ST Elevation Myocardial Infarction

Presenter: Uwe Zeymer

September 01, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

$Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction Primary results of the PARAGON-HF trial$

Presentation ESC 2019

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

Presenter: Scott D. Solomon

September 01, 2019

Presentation ESC 2019

A Risk Based Approach to the Role of Aspirin on Cardiovascular Risk Reduction in a Healthy Older Cohort

Presenter: Christopher M Reid

September 01, 2019

Presentation ESC 2019

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

Presenter: David B. Brieger

September 01, 2019

Advertisement

PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

One-year Outcomes After ST Elevation Myocardial Infarction

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

A Risk Based Approach to the Role of Aspirin on Cardiovascular Risk Reduction in a Healthy Older Cohort

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content